Coherus Biosciences Inc
CHRS
Market Cap$240.62M
Close$
$7.71
305.8% upside
Current Fair Value
305.8% upsideUndervalued by 305.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $240.62 Million |
|---|---|
| Enterprise Value | $597.31 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.53 |
| Beta | 2.36 |
| Outstanding Shares | 113,498,415 |
| Avg 30 Day Volume | 1,493,078 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.01 |
|---|---|
| PEG | -2.87 |
| Price to Sales | 0.95 |
| Price to Book Ratio | -0.95 |
| Enterprise Value to Revenue | 2.32 |
| Enterprise Value to EBIT | -2.94 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.79 |
| Debt to Equity | -2.45 |
Revenue Sources
No data
ESG Score
No data
About Coherus Biosciences Inc
CEO: Dennis Lanfear